While the ongoing healthcare debate in Congress creating a lot of uncertainty among the healthcare industry, there are areas of certainty and optimism, said Dan Todd, JD, principal at Todd Strategy.
While the ongoing healthcare debate in Congress creating a lot of uncertainty among the healthcare industry, there are areas of certainty and optimism, said Dan Todd, JD, principal at Todd Strategy.
Transcript
How is the ongoing debate around the future of healthcare in the United States weighing on the healthcare industry?
Wll certaintly with regard to the Affordable Care Act, I don't think there's as much certainty as people would like. There are still debates in Congress on the Graham-Cassidy repeal proposal, the Republicans in the Senate have until September 30 to use the budget reconciliation process. So those discussions are still ongoing, and I think some of the bigger interests, the hospitals, the health insurance companies, still have a lot of anxiety around that.
We aren't yet at a point where we're having a discussion of bipartisan stabilization efforts. I think the health committee is trying, Senator Lamar Alexander and Senator Patty Murray, but I guess I'm not as optimistic about the outcome yet, because it seems we've got limited buy in across the board.
What areas of certainty or optimism remain for the healthcare industry?
So, certainly I think with the health plans, the Medicare Advantage plan is a real focus for them and a priority, and certaintly with this administration, consistent with previous Republican administrations, there's a lot of effort to support the program and expand its popularity with the beneficiaries. And it's obviously an important line of business for the plans, so I think that is certainly consistent and growing, and will only grow in importance.
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More